Source:http://www4.wiwiss.fu-berlin.de/dailymed/resource/drugs/1662
| Predicate | Object |
|---|---|
| rdf:type | |
| rdfs:label |
Erythromycin (Solution)
|
| dailymed-instance:dosage |
The erythromycin pledget should be rubbed over the affected area twice a day after the skin is thoroughly washed with warm water and soap and patted dry. Acne lesions on the face, neck, shoulder, chest, and back may be treated in this manner. Additional pledgets may be used, if needed. Each pledget should be used once and discarded.
|
| dailymed-instance:descripti... |
Erythromycin Pledgets USP, 2% contain erythromycin, USP for topical dermatologic use. Erythromycin is a macrolide antibiotic produced from a strain of Saccaropolyspora erythraea (formerly Streptomyces erythreus). It is a base and readily forms salts with acids. Chemically, erythromycin is CHNOIt has the following structural formula: The chemical name for erythromycin is (3R*,4S*,5S* ,6R* ,7R* ,9R* ,11R* , 12R* ,13S*, 14R*)-4-[(2,6-Dideoxy-3-C-methyl-3-O-methyl-��-L-ribo-hexopyranosyl)oxy]-14-ethy1-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-[[3,4,6-trideoxy-3-(dimethylamino)-��-D-xylo-hexopyranosyl]oxy]oxacyclotetradecane-2,10-dione. Erythromycin has the molecular weight of 733.94. It is a white or slightly yellow, crystalline powder, slightly soluble in water, soluble in alcohol, in chloroform, and in ether. It is odorless or practically odorless. It has a pH range between 8.0 and 10.5 in a methanol and water solution prepared by diluting 1 volume of a methanol solution, containing 40 mg per mL, with 19 volumes of water. Each mL of expressible liquid contains 20 mg erythromycin in a base of alcohol (68.5%) (denatured with tert-butyl alcohol and denatonium benzoate), propylene glycol and citric acid to adjust pH. Each pledget is filled to contain 0.8 mL of erythromycin topical solution.
|
| dailymed-instance:clinicalP... |
The exact mechanism by which erythromycin reduces lesions of acne vulgaris is not fully known: however, the effect appears to be due in part to the antibacterial activity of the drug.
|
| dailymed-instance:activeIng... | |
| dailymed-instance:contraind... |
Erythromycin Pledgets are contraindicated in those individuals who have shown hypersensitivity to any of its components.
|
| dailymed-instance:supply |
Erythromycin Pledgets USP, 2% are available in a box of individually wrapped pledgets in the following size. 60 pledgets - NDC 59366-2838-6 Each pledget is filled to contain 0.8 mL of erythromycin topical solution. Store at controlled room temperature between 15��and 30��C (59��and 86��F). CAUTION: Federal law prohibits dispensing without prescription. Manufactured by Stiefel Laboratories, Inc., Coral Gables, FL 33134 for Glades Pharmaceuticals, Inc., Coral Gables, FL 33134 Questions? Please call 1-888-4GLADES 1-888-445-2337 84587 Rev. 0696
|
| dailymed-instance:genericDr... | |
| dailymed-instance:activeMoi... | |
| dailymed-instance:inactiveI... | |
| dailymed-instance:precautio... |
General: For topical use only; not for ophthalmic use. Concomitant topical acne therapy should be used with caution because a possible cumulative irritancy effect may occur, especially with the use of peeling, desquamating, or abrasive agents. The use of antibiotic agents may be associated with the overgrowth of antibiotic-resistant organisms. If this occurs, discontinue use and take appropriate measures. Avoid contact with eyes and all mucous membranes.<br/>Information for Patients: Patients using Erythromycin Pledgets should receive the following information and instructions:<br/>Carcinogenesis, Mutagenesis, Impairment of Fertility: No animal studies have been performed to evaluate the carcinogenic and mutagenic potential or effects on fertility of topical erythromycin. However, long-term (2-year) oral studies in rats with erythromycin ethylsuccinate and erythromycin base did not provide evidence of tumorigenicity. There was no apparent effect on male or female fertility in rats fed erythromycin (base) at levels up to 0.25% of diet.<br/>Pregnancy:<br/>Teratogenic effects:<br/>Nursing Women: It is not known whether erythromycin is excreted in human milk after topical application. However, erythromycin is excreted in human milk following oral and parenteral erythromycin administration. Therefore, caution should be exercised when erythromycin is administered to a nursing woman.<br/>Pediatric Use: Safety and effectiveness of this product in pediatric patients have not been established.
|
| dailymed-instance:genericMe... |
erythromycin
|
| dailymed-instance:fullName |
Erythromycin (Solution)
|
| dailymed-instance:adverseRe... |
The following local adverse reactions have been reported occasionally: peeling, dryness, itching, erythema, and oiliness. Irritation of the eyes and tenderness of the skin have also been reported with topical use of erythromycin. Generalized urticarial reactions, possibly related to the use of erythromycin, which required systemic steroid therapy have been reported.
|
| dailymed-instance:warning |
Pseudomembranous colitis has been reported with nearly all antibacterial agents, including erythromycin, and may range in severity from mild to life-threatening. Therefore, it is important to consider this diagnosis in patients who present with diarrhea subsequent to the administration of antibacterial agents. Treatment with antibacterial agents alters the normal flora of the colon and may permit overgrowth of clostridia. Studies indicate that a toxin produced by Clostridium difficile is one primary cause of "antibiotic-associated colitis". After the diagnosis of pseudomembranous colitis has been established, therapeutic measures should be initiated. Mild cases of pseudomembranous colitis usually respond to drug discontinuation alone. In moderate to severe cases, consideration should be given to management with fluids and electrolytes, protein supplementation and treatment with an antibacterial drug clinically effective against C. difficile colitis.
|
| dailymed-instance:indicatio... |
Erythromycin Pledgets are indicated for the topical treatment of acne vulgaris.
|
| dailymed-instance:represent... | |
| dailymed-instance:routeOfAd... | |
| dailymed-instance:name |
Erythromycin
|